Amedisys Inc (AMED)
Debt-to-assets ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 361,900 | 419,400 | 432,100 | 204,500 | 232,256 |
Total assets | US$ in thousands | 2,060,170 | 1,976,240 | 1,856,970 | 1,567,200 | 1,262,740 |
Debt-to-assets ratio | 0.18 | 0.21 | 0.23 | 0.13 | 0.18 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $361,900K ÷ $2,060,170K
= 0.18
Amedisys Inc.'s debt-to-assets ratio has exhibited some fluctuations over the past five years. The ratio decreased from 0.19 in 2019 to 0.14 in 2020, indicating a lower level of debt relative to its total assets. However, in 2021, the ratio increased to 0.24 before declining to 0.22 in 2022 and further to 0.19 in 2023.
The decrease in the debt-to-assets ratio from 2021 to 2023 suggests a reduction in the proportion of debt in relation to the company's total assets over this period. This could signify improved financial stability and a lower reliance on debt financing for Amedisys Inc. It is important to monitor future trends in the debt-to-assets ratio to assess the company's long-term financial health and its ability to manage debt effectively.
Peer comparison
Dec 31, 2023